Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Gross Profit

Aerie Pharmaceuticals Gross Profit Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Gross Profit from 2017 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Aerie Pharmaceuticals Gross Profit for the quarter ending September 09, 2020 was $15m a -11.88% decrease of -2m year over year
  • Aerie Pharmaceuticals Gross Profit for the last 12 months ending September 09, 2020 was $54m a 21.21% increase of 11m year over year
  • Aerie Pharmaceuticals Annual Gross Profit for 2019 was $42m a 107.11% increase of 45m from 2018
  • Aerie Pharmaceuticals Annual Gross Profit for 2018 was $-3m a -456.07% increase of 14m from 2017
  • Aerie Pharmaceuticals Annual Gross Profit for 2017 was $-17m a 41.52% decrease of -7m from 2016
Other Income Statement Metrics:
  • Aerie Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $-51m a 21.13% decrease of -11m year over year
  • Aerie Pharmaceuticals Net Income for the quarter ending December 12, 2018 was $-51m a 20.91% decrease of -11m year over year
  • Aerie Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $7m
View Chart On Koyfin

Quarterly AERI Gross Profit Data

09/2020$15m
06/2020$11m
03/2020$12m
12/2019$16m
09/2019$11m
06/2019$9m
03/2019$6m
12/2018$6m
09/2018$0m
06/2018$-4m

Annual AERI Gross Profit Data

2019$42m
2018$-3m
2017$-17m
2016$-10m